We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.
MBII

Delisted

MBII was delisted on the 12th of July, 2022.

Back to rankings

49 hedge funds and large institutions have $35.8M invested in Marrone Bio Innovations, Inc. in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 7 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

257% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 7

22% less funds holding

Funds holding: 63 → 49 (-14)

61% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 23

67% less call options, than puts

Call options by funds: $2K | Put options by funds: $6K

81% less capital invested

Capital invested by funds: $191M → $35.8M (-$155M)

Holders
49
Holders Change
-14
Holders Change %
-22.22%
% of All Funds
1.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
25
Reduced
7
Closed
23
Calls
$2K
Puts
$6K
Net Calls
-$4K
Net Calls Change
-$22K

Top Buyers

Rank Fund Capital Flow
1
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$2.13M
2
Primecap Management
Primecap Management
California
+$1.34M
3
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
+$1.13M
4
TC
TFS Capital
Pennsylvania
+$1.06M
5
SM
Senvest Management
New York
+$906K

Top Sellers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
-$11.4M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.21M
3
PWAM
Park West Asset Management
California
-$6.87M
4
KCM
Kornitzer Capital Management
Kansas
-$4.76M
5
Principal Financial Group
Principal Financial Group
Iowa
-$2.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
51
Kornitzer Capital Management
Kansas
– -$4.76M -409,450 Closed
Principal Financial Group
52
Principal Financial Group
Iowa
– -$2.09M -180,000 Closed
NIP
53
Nicholas Investment Partners
California
– -$1.63M -140,111 Closed
AAP
54
Ardsley Advisory Partners
Connecticut
– -$1.13M -97,500 Closed
AP
55
Alydar Partners
Massachusetts
– -$813K -70,000 Closed
GH
56
GAM Holding
Switzerland
– -$569K -49,000 Closed
COPPSERS
57
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$318K -27,349 Closed
Tudor Investment Corp
58
Tudor Investment Corp
Connecticut
– -$295K -25,391 Closed
EEG
59
E.E. Geduld
– -$291K -25,000 Closed
California Public Employees Retirement System
60
California Public Employees Retirement System
California
– -$272K -23,399 Closed
Jane Street
61
Jane Street
New York
– -$225K -19,398 Closed
ACM
62
Archon Capital Management
Washington
– -$180K -15,500 Closed
RFS
63
Rockefeller Financial Services
New York
– -$167K -14,413 Closed
PP
64
PDT Partners
New York
– -$162K -13,945 Closed
Millennium Management
65
Millennium Management
New York
– -$147K -12,635 Closed
LPL Financial
66
LPL Financial
California
– -$131K -11,263 Closed
Susquehanna International Group
67
Susquehanna International Group
Pennsylvania
– -$120K -10,294 Closed
MAA
68
Managed Account Advisors
New Jersey
– -$14K -1,188 Closed
VFA
69
Virtus Fund Advisers
Connecticut
– -$11K -965 Closed
Bank of Montreal
70
Bank of Montreal
Ontario, Canada
– -$2K -150 Closed
GSC
71
Ground Swell Capital
South Carolina
– -$1K -47 Closed
1 2
3

MBII Hedge Fund Activity: Q3 2014 in Review

49 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q3 2014, worth a combined $35.8M — down 81% from $191M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of MBII and 9 opened new positions — a net loss of 14 holders — while 7 trimmed existing stakes and 25 added.

The largest buyer was Massachusetts Financial Services, adding an estimated $2.13M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $11.4M.

  • 49 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q3 2014, down from 63 in Q2 2014.
  • Funds reported $35.8M of Marrone Bio Innovations, Inc. stock for Q3 2014, down 81% quarter-over-quarter.
  • 9 funds opened new Marrone Bio Innovations, Inc. positions in Q3 2014 and 23 closed out, a net change of -14 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q3 2014 was Massachusetts Financial Services, an estimated $2.13M added.
  • The largest Marrone Bio Innovations, Inc. seller in Q3 2014 was Gilder Gagnon Howe & Co, an estimated $11.4M sold.

Based on aggregated 13F filings for Q3 2014.